# Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

> **NCT03435172** · NA · SUSPENDED · sponsor: **Cytori Therapeutics** · enrollment: 15 (estimated)

## Conditions studied

- Thermal Burn

## Interventions

- **DEVICE:** Device-ADRCs intravenously infusion

## Key facts

- **NCT ID:** NCT03435172
- **Lead sponsor:** Cytori Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-04-01
- **Primary completion:** 2020-07-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 15 (ESTIMATED)
- **Why stopped:** Low enrollment rate, voluntary study suspension of the study
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03435172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03435172, "Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03435172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*